WOONSOCKET, R.I., Sept. 13,
2022 /PRNewswire/ -- CVS Health® (NYSE: CVS) has
appointed Jeffrey R. Balser, M.D.,
Ph.D., to serve on the Board of Directors (the "Board") of CVS
Health, effective immediately. He has also been named to the
Board's Medical Affairs Committee.
"Dr. Balser's extensive experience in a wide range of roles
across health care organizations will be an invaluable asset for
the Board," said CVS Health President and CEO Karen S. Lynch. "His deep clinical expertise and
leadership of a prestigious health system gives him the insight to
help support our strategy to serve consumers and meet their health
needs differently."
Dr. Balser serves as President and Chief Executive Officer of
Vanderbilt University Medical Center
("VUMC") and has served as its chief executive since 2009, and has
also served as Dean of the Vanderbilt
University School of Medicine since 2008. VUMC is one of the
largest and most prominent academic medical centers in the
Southeast, with seven hospitals and 170 outpatient facilities
across Tennessee and in
neighboring states.
"On behalf of the Board, I want to welcome Dr. Balser to CVS
Health," said Roger N. Farah,
Independent Chair of the Board. "This is an exciting time for the
Company, and we are confident he will be a valuable addition as we
continue to redefine health care."
Dr. Balser is a member of the National Academy of Medicine and
serves on its governing council. He also currently serves on the
boards of VUMC, Tulane University, and
the Nashville Health Care Council.
"I believe CVS Health's vision for primary care and its
integrated approach to care delivery will help improve the health
experience in our country," Dr. Balser said. "I look forward to
working with the management team and the Board to help advance the
company's strategy."
Dr. Balser completed his internship with the Osler Medical
Service, residency training in anesthesiology, and fellowship
training in both cardiac anesthesiology and critical care medicine
at Johns Hopkins in Baltimore, MD. He joined the Hopkins faculty
in 1995, practicing cardiac anesthesiology and ICU medicine while
leading an NIH-funded research program aimed at the genomic
underpinnings of cardiac rhythm disorders. He returned to
Vanderbilt in 1998, was appointed chair
of the Department of Anesthesiology in 2001 and became VUMC's chief
research officer in 2004. In 2008/09, he was named Dean of the
School of Medicine and Vice Chancellor for Health affairs with
executive responsibility for Vanderbilt's medicine-related educational,
research, and clinical service programs, responsibilities that
continue since 2016 in his role as President and CEO.
About CVS Health
CVS Health® is the leading
health solutions company, delivering care like no one else can. We
reach more people and improve the health of communities across
America through our local presence, digital channels and over
300,000 dedicated colleagues – including more than 40,000
physicians, pharmacists, nurses and nurse practitioners. Wherever
and whenever people need us, we help them with their health –
whether that's managing chronic diseases, staying compliant with
their medications or accessing affordable health and wellness
services in the most convenient ways. We help people navigate the
health care system – and their personal health care – by improving
access, lowering costs and being a trusted partner for every
meaningful moment of health. And we do it all with heart, each and
every day. Follow @CVSHealth on social
media.
Media contact
T.J. Crawford
212-457-0583
CrawfordT2@CVSHealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@CVSHealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cvs-health-appoints-dr-jeffrey-balser-to-board-of-directors-301622396.html
SOURCE CVS Health